Lysosome dysfunction in the pathogenesis of kidney diseases.

scientific article

Lysosome dysfunction in the pathogenesis of kidney diseases. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1023194040
P356DOI10.1007/S00467-013-2652-Z
P932PMC publication ID4018427
P698PubMed publication ID24217784

P50authorKameswaran SurendranQ83763706
P2093author name stringDavid A Pearce
Seasson P Vitiello
P2860cites workCystinosisQ24262959
The targeting of cystinosin to the lysosomal membrane requires a tyrosine-based signal and a novel sorting motifQ24290722
Megalin and cubilin: multifunctional endocytic receptorsQ24296807
Decreased intracellular ATP content and intact mitochondrial energy generating capacity in human cystinotic fibroblastsQ24302197
OCRL localizes to the primary cilium: a new role for cilia in Lowe syndromeQ24318114
A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosisQ24322985
Lowe syndrome protein OCRL1 interacts with clathrin and regulates protein trafficking between endosomes and the trans-Golgi networkQ24534275
WNK4 enhances the degradation of NCC through a sortilin-mediated lysosomal pathwayQ24652877
Cystinosis: the evolution of a treatable diseaseQ26863651
Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporterQ27937730
ERS1 encodes a functional homologue of the human lysosomal cystine transporterQ27940319
Severity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosinQ28137732
Characterization of renal chloride channel (CLCN5) mutations in Dent's diseaseQ28141493
LIMP-2/LGP85 deficiency causes ureteric pelvic junction obstruction, deafness and peripheral neuropathy in miceQ28181137
Human hypertension caused by mutations in WNK kinasesQ28212182
OCRL1 mutations in Dent 2 patients suggest a mechanism for phenotypic variabilityQ28242430
A nonsense mutation in the LIMP-2 gene associated with progressive myoclonic epilepsy and nephrotic syndromeQ28277094
Isolation of a novel gene underlying Batten disease, CLN3. The International Batten Disease ConsortiumQ28288921
Tubular proteinuria in mice and humans lacking the intrinsic lysosomal protein SCARB2/Limp-2Q28307851
Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubulesQ28592336
Upregulation of the Rab27a-dependent trafficking and secretory mechanisms improves lysosomal transport, alleviates endoplasmic reticulum stress, and reduces lysosome overload in cystinosisQ30541728
Autophagy sequesters damaged lysosomes to control lysosomal biogenesis and kidney injuryQ30544606
A futile cycle, formed between two ATP-dependant gamma-glutamyl cycle enzymes, gamma-glutamyl cysteine synthetase and 5-oxoprolinase: the cause of cellular ATP depletion in nephrotic cystinosis?Q33348982
Mitochondrial autophagy promotes cellular injury in nephropathic cystinosisQ33711275
Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN).Q33988780
The coincidence of IgA nephropathy and Fabry diseaseQ34543669
The WNKs: atypical protein kinases with pleiotropic actions.Q34560188
Renal pathology in Fabry disease.Q34688823
Mouse model for Lowe syndrome/Dent Disease 2 renal tubulopathyQ34695333
Osmotic stress changes the expression and subcellular localization of the Batten disease protein CLN3.Q34805162
Endocytosis provides a major alternative pathway for lysosomal biogenesis in kidney proximal tubular cellsQ35720129
Protein reabsorption in renal proximal tubule-function and dysfunction in kidney pathophysiologyQ35775018
Role of adenosine triphosphate (ATP) and NaK ATPase in the inhibition of proximal tubule transport with intracellular cystine loading.Q35819885
Cellular and molecular mechanisms of renal fibrosisQ35903772
mVps34 deletion in podocytes causes glomerulosclerosis by disrupting intracellular vesicle traffickingQ36574743
Hematopoietic stem cell gene therapy for the multisystemic lysosomal storage disorder cystinosisQ36673678
Nephropathic cystinosis: late complications of a multisystemic diseaseQ37002855
Deficiency of the tetraspanin CD63 associated with kidney pathology but normal lysosomal functionQ37099908
Fibrosis: a key feature of Fabry disease with potential therapeutic implicationsQ37113004
Osmoregulation of ceroid neuronal lipofuscinosis type 3 in the renal medullaQ37174221
Renal complications of Fabry disease in childrenQ37265117
Trafficking and function of the tetraspanin CD63.Q37302224
Molecular mechanisms of receptor-mediated endocytosis in the renal proximal tubular epithelium.Q37654819
The pathogenesis of cystinosis: mechanisms beyond cystine accumulationQ37786450
Glycosphingolipids and kidney diseaseQ37930558
Congenital nephrogenic diabetes insipidus: the current state of affairsQ37994652
OCRL controls trafficking through early endosomes via PtdIns4,5P₂-dependent regulation of endosomal actinQ39463370
Vps34 deficiency reveals the importance of endocytosis for podocyte homeostasisQ40129029
Hemizygous Fabry disease associated with IgA nephropathy: a case report.Q40377725
Recent advances in the treatment of cystinosisQ40379210
Glutathione precursors replenish decreased glutathione pool in cystinotic cell linesQ40508227
Early renal changes in hemizygous and heterozygous patients with Fabry's diseaseQ41410955
Detection and characterization of carrier-mediated cationic amino acid transport in lysosomes of normal and cystinotic human fibroblasts. Role in therapeutic cystine removal?Q41917152
Glutathione depletion and increased apoptosis rate in human cystinotic proximal tubular cellsQ42491489
p62/SQSTM1 prominently accumulates in renal proximal tubules in nephropathic cystinosisQ42508251
Renal phenotype of the cystinosis mouse model is dependent upon genetic backgroundQ43257283
Lysosomal cystine storage augments apoptosis in cultured human fibroblasts and renal tubular epithelial cellsQ44223955
Treatment of cystinosis with delayed-release cysteamine: 6-year follow-up.Q46025928
Elevated oxidized glutathione in cystinotic proximal tubular epithelial cellsQ46734471
Strict cysteamine dose regimen is required to prevent nocturnal cystine accumulation in cystinosisQ46776598
Impaired activity of the gamma-glutamyl cycle in nephropathic cystinosis fibroblastsQ46913688
Mouse model of proximal tubule endocytic dysfunction.Q50511874
Fabry disease: a morphologic study of 11 cases.Q51798460
Late onset neurodegeneration in the Cln3-/- mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation.Q52087477
ClC-5 Cl- -channel disruption impairs endocytosis in a mouse model for Dent's disease.Q52541657
Mice lacking renal chloride channel, CLC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis.Q52541771
ATP-dependent lysosomal cystine efflux is defective in cystinosisQ53563602
Increased apoptosis in cystinotic fibroblasts and renal proximal tubule epithelial cells results from cysteinylation of protein kinase Cdelta.Q53587514
Isolation of a novel gene underlying batten disease, CLN3Q56804260
Kidney histologic alterations in α-Galactosidase-deficient miceQ59182412
Kidney biopsy findings in heterozygous Fabry disease females with early nephropathyQ59182497
Improved renal function in children with cystinosis treated with cysteamineQ70617637
Cystine: Compartmentalization within Lysosomes in Cystinotic LeukocytesQ71229621
Increased Cystine in Leukocytes from Individuals Homozygous and Heterozygous for CystinosisQ72254080
Early development of the renal lesions in infantile cystinosisQ73233049
Microdissection of the nephron in diseaseQ74521663
The Fanconi syndrome with cystinossis. Electron microscopy of renal biopsy specimens from five patientsQ79535772
Distribution of alpha-galactosidase A in normal human kidney and renal accumulation and distribution of recombinant alpha-galactosidase A in Fabry miceQ79743394
IgA nephropathy in two adolescent sisters heterozygous for Fabry diseaseQ79895535
High incidence of autoantibodies in Fabry disease patientsQ80215879
Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knockin mouse modelQ80292340
Increased free-cystine content of fibroblasts cultured from patients with cystinosisQ82640892
Cysteamine restores glutathione redox status in cultured cystinotic proximal tubular epithelial cellsQ83523305
Fabry disease and immunoglobulin A nephropathyQ85305776
Hereditary nephrogenic diabetes insipidus in Japanese patients: analysis of 78 families and report of 22 new mutations in AVPR2 and AQP2Q85428926
Lysosomal cystine storage in cystinosis and mucolipidosis type IIQ93651736
P433issue12
P921main subjectpathogenesisQ372016
P304page(s)2253-2261
P577publication date2013-11-12
P1433published inPediatric NephrologyQ15749796
P1476titleLysosome dysfunction in the pathogenesis of kidney diseases
P478volume29

Reverse relations

cites work (P2860)
Q36500470A Two-Photon Fluorescent Probe for Lysosomal Thiols in Live Cells and Tissues
Q52779493A lysosome-targeted fluorescent chemodosimeter for monitoring endogenous and exogenous hydrogen sulfide by in vivo imaging.
Q58608039A lysosome-targeting nanosensor for simultaneous fluorometric imaging of intracellular pH values and temperature
Q40974192Cathepsin D in Podocytes Is Important in the Pathogenesis of Proteinuria and CKD.
Q40175140Genetic-Variation-Driven Gene-Expression Changes Highlight Genes with Important Functions for Kidney Disease
Q64267452Lysosome-Targeted Single Fluorescence Probe for Two-Channel Imaging Intracellular SO₂ and Biothiols
Q47171560The Multifaceted Role of the Lysosomal Protease Cathepsins in Kidney Disease.

Search more.